DNA vaccines aim to supercharge immune therapy against skin cancer
Disease control
Ongoing
This phase 2 trial is testing two experimental DNA vaccines, SCIB1 and iSCIB1+, in combination with standard immunotherapy drugs for people with advanced melanoma that cannot be removed by surgery. The study involves 173 participants and aims to see if adding these vaccines is sa…
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC